117 related articles for article (PubMed ID: 1097097)
1. Evaluation of daunorubicin (NSC-82151) and methotrexate (NSC-740) in combination as a remission maintenance regimen in the treatment of acute leukemia.
Humphrey B; Fernbach DJ; Razek AA; Stuckey WJ; Komp D; George S
Cancer Chemother Rep; 1975; 59(2 Pt 1):395-9. PubMed ID: 1097097
[TBL] [Abstract][Full Text] [Related]
2. Daunorubicin (NSC-83142) versus daunorubicin plus prednisone (NSC-10023) versus daunorubicin plus vincristine (NSC-67574) plus prednisone in advanced childhood acute lymphocytic leukemia.
Jones B; Cuttner J; Levy RN; Patterson RB; Kung F; Pleuss HJ; Falkson G; Treat CL; Haurani F; Burgert EO; Rosner F; Carey RW; Lukens J; Blom J; Degnan TJ; Wohl H; Glidewell O; Holland JF
Cancer Chemother Rep; 1972 Dec; 56(6):729-37. PubMed ID: 4574054
[No Abstract] [Full Text] [Related]
3. Combination therapy in 130 patients with acute lymphoblastic leukemia (protocol 06 LA 66-Paris).
Jacquillat C; Weil M; Gemon MF; Auclerc G; Loisel JP; Delobel J; Flandrin G; Schaison G; Izrael V; Bussel A; Dresch C; Weisgerber C; Rain D; Tanzer J; Najean Y; Seligmann M; Boiron M; Bernard J
Cancer Res; 1973 Dec; 33(12):3278-84. PubMed ID: 4519131
[No Abstract] [Full Text] [Related]
4. Daunorubicin (NSC-83142) in advanced childhood leukemia.
Jaffe N; Traggis DG; Das L
Cancer Chemother Rep; 1974; 58(5 Pt 1):661-5. PubMed ID: 4529663
[No Abstract] [Full Text] [Related]
5. Daunorubicin (NSC-82151), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) combination therapy for advanced adult acute leukemia.
Burns CP
Cancer Chemother Rep; 1975; 59(4):757-60. PubMed ID: 1100227
[No Abstract] [Full Text] [Related]
6. Sequential therapy with daunorubicin and L-asparaginase in relapses of acute lymphoblastic leukemia in children.
Masera G; Uderzo C; Corbella E; Carnelli V
Acta Haematol; 1978; 59(4):205-14. PubMed ID: 417542
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of acute lymphoblastic leukosis: evaluation of the maintenance and reinduction standards. Analysis of 33 cases].
Raichs A; Torres A; Giralt M; Aztarain E
Sangre (Barc); 1972; 17(1):115-24. PubMed ID: 4502098
[No Abstract] [Full Text] [Related]
8. [Acute lymphatic leukemia in children in the Netherlands; study ALL I, 1972-1973; Dutch Childhood Leukemia Study Group].
van der Does-van den Berg A; de Koning J; Reerink H; de Vries JA; van Zanen GE
Ned Tijdschr Geneeskd; 1975 Sep; 119(38):1445-51. PubMed ID: 1101081
[No Abstract] [Full Text] [Related]
9. Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.
Wiernik PH; Schimpff SC; Schiffer CA; Lichtenfeld JL; Aisner J; O'Connell MJ; Fortner C
Cancer Treat Rep; 1976 Jan; 60(1):41-53. PubMed ID: 1069608
[TBL] [Abstract][Full Text] [Related]
10. Comparison of CNS-leukaemia in children with acute leukaemia, induced either with rubidomycin or L-asparaginase.
de Vaan GA; Marcar JR; Schretlen ED
Padiatr Padol; 1971; 6(3):230-9. PubMed ID: 5293526
[No Abstract] [Full Text] [Related]
11. Proceedings: Daunorubicin cardiac toxicity in children with acute lymphocytic leukemia.
Halazun JF; Wagner HR; Gaeta JF; Sinks LF
Cancer; 1974 Feb; 33(2):545-54. PubMed ID: 4521474
[No Abstract] [Full Text] [Related]
12. [Treatment of acute lymphoblastic leukemia].
Paolucci G; Rosito P
Minerva Pediatr; 1971 Nov; 23(44):1851-69. PubMed ID: 4950250
[No Abstract] [Full Text] [Related]
13. Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia.
Yates JW; Wallace HJ; Ellison RR; Holland JF
Cancer Chemother Rep; 1973; 57(4):485-8. PubMed ID: 4586956
[No Abstract] [Full Text] [Related]
14. Evaluation of induction of remission, intensification, and central nervous system prophylactic treatment in acute lymphoblastic leukemia.
Sackmann Muriel F; Pavlovsky S; Peñalver JA; Hidalgo G; Cebrian Bonesana A; Eppinger-Helft M; De Macchi GH; Pavlovsky A
Cancer; 1974 Aug; 34(2):418-26. PubMed ID: 4527793
[No Abstract] [Full Text] [Related]
15. [Therapy of acute leukemia. 4. Remission induction and remission maintenance therapy].
Hirano M; Uetani T; Morita A; Sako F; Koie K
Saishin Igaku; 1971 Oct; 26(10):2034-41. PubMed ID: 5288692
[No Abstract] [Full Text] [Related]
16. [Treatment of acute leukemias].
Brilliant MD
Ter Arkh; 1973 Sep; 45(9):72-85. PubMed ID: 4585646
[No Abstract] [Full Text] [Related]
17. [Acute lymphatic leukemia in adults. Therapy and prognosis in comparison with acute myelogenous leukemia].
Abbrederis K; Michlmayr G; Schmalzl F
Med Klin; 1974 Mar; 69(10):427-31. PubMed ID: 4524609
[No Abstract] [Full Text] [Related]
18. Treatment of acute lymphoblastic leukemia in children. Long-term results of two trials.
Cáp J; Koza I; Misíková Z; Foltinová A; Strbáková E
Neoplasma; 1983; 30(1):81-92. PubMed ID: 6339961
[TBL] [Abstract][Full Text] [Related]
19. Intermittent therapy with 6-mercaptopurine (NSC-755) and methotrexate (NSC-740) given intravenously to adults with acute leukemia.
Ellison RR; Hoogstraten B; Holland JF; Levy RN; Lee SL; Silver RT; Leone LA; Cooper T; Oberfield RA; Ten Pas A; Blom J; Jacquillat C; Haurani F
Cancer Chemother Rep; 1972 Aug; 56(4):535-42. PubMed ID: 4507688
[No Abstract] [Full Text] [Related]
20. Therapeutic considerations in acute lymphocytic leukemia.
Holland JF
Am J Pathol; 1978 Feb; 90(2):521-8. PubMed ID: 272122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
